Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-15-000150
Filing Date
2015-02-18
Accepted
2015-02-18 17:06:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 18, 2015 vistagen13ga-021815.htm SC 13G/A 119297
  Complete submission text file 0001013594-15-000150.txt   120912
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-86249 | Film No.: 15628834
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019 212-271-7866
Platinum Long Term Growth VII, LLC (Filed by) CIK: 0001413041 (see all company filings)

EIN.: 412203299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A